Full-Time

Market Access Manager

Posted on 3/13/2025

Takeda

Takeda

10,001+ employees

Develops and commercializes biopharmaceuticals and vaccines

No salary listed

Senior

Madrid, Spain

Category
Business Research
Strategy Development
Business Development
Business & Strategy
Requirements
  • Bachelor’s degree in Business Administration, Health Economics, Life Sciences, or a related field; Master’s degree or MBA preferred.
  • Minimum of 5 years in market access, pricing, reimbursement, or related fields within the pharmaceutical industry.
  • Strong analytical and economic evaluation skills, capable of conducting advanced research and analysis.
  • Excellent communication and negotiation skills to effectively engage with stakeholders and negotiate contracts.
  • Proven experience in developing and executing complex market access and pricing strategies.
  • Leadership skills to lead and mentor project teams, fostering a collaborative environment.
  • Ability to work cross-functionally and represent the Market Access department within Business Units.
  • Strong understanding of national and international healthcare systems and reimbursement mechanisms.
  • Ability to design and implement projects aligned with business objectives and market needs.
  • Proficiency in market access tools and economic modeling software.
  • Familiarity with regulatory requirements, health technology assessments, and reimbursement processes.
Responsibilities
  • Develop and align within different team’s market access strategy
  • Conduct advanced market research and lead complex studies
  • Communicate effectively with stakeholders to ensure the drug's/device's value proposition is recognized
  • Perform advanced economic analysis and make improvement recommendations
  • Lead project teams, providing guidance and mentorship in market access strategies
  • Negotiate contracts and represent the organization in project matters with senior external personnel
  • Design and implement institutional projects aligned with organizational goals
  • Act as the Market Access department’s representative within the Business Units, ensuring strategic alignment and integration of key initiatives
  • Applies advanced market research techniques, capable of leading complex studies and advising others on market insights.
  • Develops and executes market strategies, capable of handling highly complex scenarios and coaching others.
  • Communicates effectively with stakeholders, ensuring the drug's/device's value proposition is recognized and acted upon.
  • Performs advanced economic analysis, applies principles in highly complex situations, advises others, and makes improvement recommendations.
  • Leads project teams, providing guidance and mentorship in market access strategies.
  • Negotiates contracts and represents the organization in project matters with senior external personnel.
  • Designs and implements pricing strategies in collaboration with Health Economics/Outcomes Research.
  • Mentors team members, enhancing their skills in market access and strategic planning.
  • Analyzes competitive intelligence, capable of advising based on insights and handling complex analysis.
  • Leads commercialization efforts, advising others and anticipating market requirements for novel products.
Desired Qualifications
  • Master’s degree or MBA preferred.

Takeda Pharmaceutical Company Limited is a global biopharmaceutical firm that focuses on developing and delivering treatments and vaccines. The company invests heavily in research and development to create new molecular entities (NMEs) and commercialize them, with a goal of launching up to 15 new products by FY2024. Takeda's products are designed to meet the needs of healthcare providers, hospitals, and patients around the world. What sets Takeda apart from its competitors is its strong commitment to patient-centric values and environmental sustainability, recognizing the connection between human health and environmental health. The company's goal is to provide life-changing therapies while ensuring that patient needs are prioritized and environmental risks are managed.

Company Size

10,001+

Company Stage

IPO

Headquarters

Tokyo, Japan

Founded

1781

Simplify Jobs

Simplify's Take

What believers are saying

  • Takeda's collaboration with BridGene could enhance its immunology and neurology offerings.
  • The SEA AtM Summit highlights Takeda's commitment to expanding access to medicines in Asia.
  • Positive Phase III trial results for a cancer drug strengthen Takeda's oncology portfolio.

What critics are saying

  • Antitrust litigation in the US could impact Takeda's market position and reputation.
  • The $770 million deal with BridGene poses financial risks if outcomes aren't met.
  • Geopolitical risks could disrupt Takeda's global operations and supply chain.

What makes Takeda unique

  • Takeda has a 240-year history in the biopharmaceutical industry.
  • The company emphasizes patient-centric values in its operations and innovations.
  • Takeda's robust pipeline includes 11 NMEs with plans for 15 launches by FY2024.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Vacation

Paid Sick Leave

Wellness Program

Tuition Reimbursement

Company News

MLex
Mar 4th, 2025
Meijer seeks quick appeal in US antitrust case against Takeda

( March 4, 2025, 17:06 GMT | Official Statement) - MLex Summary: Meijer asked a US federal judge for leave to immediately appeal an order that sent its antitrust case against Takeda Pharmaceuticals over the drug Amitiza to arbitration.

BioSpace
Mar 3rd, 2025
Takeda-Protagonist Drug for Incurable Cancer Reduces Need for Blood Withdrawals in Phase III Trial

Protagonist, which will receive a $25 million milestone from Takeda thanks to the positive results, plans to submit the findings to regulators.

Access Health
Mar 3rd, 2025
Strengthening Access to Medicines in Southeast Asia: Highlights from Southeast Asia Access to Medicine (SEA AtM) Summit

ACCESS Health International, in collaboration with AVPN, SingHealth Duke-NUS Global Health Institute, and Takeda, successfully co-hosted the first Southeast Asia Access to Medicine (SEA AtM) Summit in Bangkok.

Pharmaceutical Technology
Feb 25th, 2025
Takeda broadens its deal with BridGene for up to $770m

Bridgene and Takeda have inked a deal worth $770m to develop small molecules for immunology and neurology.

Nyasa Times
Feb 6th, 2025
Forgotten Children: Mzimba's Tukuyu CBCC Struggles to Provide Basic Education

VillageReach, in partnership with Takeda Pharmaceutical Company Limited, has launched a new initiative aimed at strengthening health systems and improving...